National Academies Report Calls for ‘Urgent Action’ on Trial Diversity

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

National Academies Report Calls for ‘Urgent Action’ on Trial Diversity

J.W. Schomisch

May 21, 2022 at 03:14 PM EST

A congressionally mandated National Academies report released May 17 calls for “urgent action” to improve the representation of underrepresented populations in clinical trials. In addition, the American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) released a Research Statement on May 19 with six recommendations to improve equity, ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

National Academies Report Calls for ‘Urgent Action’ on Trial Diversity

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

National Academies Report Calls for ‘Urgent Action’ on Trial Diversity

My Research Folders

Related Articles

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT